Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FMZDT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,375
Award facts
- Contract value 100% obligated
- $9,375.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) with a ceiling value of $9,375.10. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. TRELEGY ELLIPTA is a combination respiratory medication used for chronic obstructive pulmonary disease management, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical products to support military and veteran healthcare systems.
This delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen's $999.999 billion DLA Troop Support Medical prime vendor contract (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The company, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant portfolio of federal medical supply contracts and has demonstrated capability to meet federal procurement requirements through open competition. As a child contract under this larger indefinite delivery vehicle, this award exemplifies the flexibility and responsiveness of the Defense Logistics Agency's pharmaceutical prime vendor program in fulfilling critical medical supply needs for defense health operations.
Quick answers
Who was awarded contract SPE2DB25FMZDT?
SPE2DB25FMZDT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FMZDT worth?
The government has obligated $9,375 on SPE2DB25FMZDT.
Is contract SPE2DB25FMZDT an order under another contract?
Yes. SPE2DB25FMZDT is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMZDT competed?
The extent of competition for SPE2DB25FMZDT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award